SCHEMBL8034352

SCHEMBL8034352

CC1(C)CCN(C[C@@H](NC(=O)N[C@H]2CCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@@H]3C4[C@H](CN3C2=O)C4(C)C)C(C)(C)C)C(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607180 1.00 — —
SCHEMBL12607905 0.93 CPB2 (0.30) —
SCHEMBL12607998 0.93 — —
SCHEMBL12608435 0.92 — —
SCHEMBL7860503 0.91 — —
SCHEMBL8056194 0.91 — —
SCHEMBL7857573 0.91 — —
SCHEMBL12607184 0.91 — —
SCHEMBL12608446 0.91 — —
SCHEMBL8045685 0.89 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058856-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2009-05-07 — — WO disclosed
Send feedback